Faecal microbiota transplantation in IBS - new evidence for success?

Affiliations

¹ Nutrition-Gut-Brain Interactions Research Centre, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
² Nutrition-Gut-Brain Interactions Research Centre, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden. robert.brummer@oru.se.

Comment

Julia König et al. Nat Rev Gastroenterol Hepatol. 2020 Apr.

. 2020 Apr;17(4):199-200.

doi: 10.1038/s41575-020-0282-z.

¹ Nutrition-Gut-Brain Interactions Research Centre, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden.
² Nutrition-Gut-Brain Interactions Research Centre, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden. robert.brummer@oru.se.

No abstract available

Comment on

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. El-Salhy M, et al. Gut. 2020 May;69(5):859-867. doi: 10.1136/gutjnl-2019-319630. Epub 2019 Dec 18. Gut. 2020. PMID: 31852769 Free PMC article. Clinical Trial.

1. König, J. et al. Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment. Pharmacol. Ther. 45, 222–239 (2017). - DOI
1. El-Salhy, M., Hatlebakk, J. G., Gilja, O. H., Brathen Kristoffersen, A. & Hausken, T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut https://doi.org/10.1136/gutjnl-2019-319630 (2019). - DOI - PubMed
1. Johnsen, P. H. et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol. Hepatol. 3, 17–24 (2018). - DOI
1. Halkjaer, S. I. et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut 67, 2107–2115 (2018). - DOI
1. Holster, S. et al. The effect of allogenic versus autologous fecal microbiota transfer on symptoms, visceral perception and fecal and mucosal microbiota in irritable bowel syndrome: a randomized controlled study. Clin. Transl Gastroenterol. 10, e00034 (2019). - DOI